Electrolyzed Reduced Water Induces Differentiation in K-562 Human Leukemia Cells
by Kiichiro Teruya, Sanetaka Shirahata, Shinkatsu Morisawa, Takaaki Komatsu, Kazumichi Otsubo, Yosinori Katakura
Abstract:
Electrolyzed reduced water (ERW) is known to scavenge reactive oxygen species (ROS) which is related to malignant tumor phenotypes. We attempted to clarify the effect of ERW on tumor phenotypes of K562 human leukemia cells. Treatment of K562 cells with ERW resulted in growth arrest, morphological changes, and expression of CD41, a cell marker of megakaryocyte differentiation. However, the morphology of N-acetylcysteine (NAC)-treated cells was rather similar to that of non-treated control K562 cells. These results suggested that ERW, but not NAC can differentiate K562 cells into megakaryocytes. The induction of megakaryocytes from K562 cells by ERW was preceded by a rapid rise in the activity of MEK (MAP kinase /extra-cellular regulated kinases) that leads to sustained activation of ERK (extra-cellular regulated kinases; MAPK). However, In NAC-treated K562 cells, ERK activation was only transient. The different persistency of ERK activation induced by ERW and NAC might affect the cell fate.
Read more:
https://doi.org/10.1007/978-94-017-0726-8_67
Related Articles:
The poor penetration of nanocarriers within tumor dense extracellular matrices (ECM) greatly restricts the access of anticancer drugs to the deep tumor cells, resulting in low therapeutic efficacy. Moreover, the high toxicity of the traditional chemotherapeutics inevitably causes undesirable side…
Aims: Doxorubicin is a drug widely used in clinical cancer treatment, but severe cardiotoxicity limits its clinical application. Autophagy disorder is an important factor in the mechanism of doxorubicin-induced cardiac injury. As the smallest molecule in nature, hydrogen has various…
Background: Ocular melanoma is a rare kind of eye malignancy that threatens the patient’s eyesight. Radiotherapy and surgical removal are the most commonly used therapeutic modalities, and nanomedicine has lately entered this field. Brachytherapy using Ruthenium-106 (106 Ru) ophthalmic plaques…
Combination therapy is an emerging strategy to overcome multidrug resistance (MDR) in hepatocellular carcinoma (HCC) chemotherapy treatment. However, the passive diffusion in traditional delivery systems greatly retards the approach and penetration of drugs into hepatocellular carcinoma cells and thus hinders…
Background: Colorectal cancer (CRC) is the third leading cause of cancer-related deaths in the world. Tumor removal remains the preferred frontline treatment; however, effective non-surgical interventions remain a high priority. 5-fluorouracil (5-FU) is a widely used chemotherapy agent, and molecular…
Molecular hydrogen ameliorates pathological states in a variety of human diseases, animal models, and cell models, but the effects of hydrogen on cancer have been rarely reported. In addition, the molecular mechanisms underlying the effects of hydrogen remain mostly unelucidated….
0 Comments